Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Manufacturers: Describe Adverse Events More Fully

This article was originally published in The Silver Sheet

Executive Summary

FDA URGES FIRMS TO COMPLETE ADVERSE EVENT REPORT NARRATIVES so the agency will better understand the nature of the incident. Meanwhile, a new chart designed by CDRH's Office of Surveillance & Biometrics describes what FDA does with the reports it receives

You may also be interested in...



Transparency website aims to improve

After receiving 46 comments about its new transparency website, CDRH said it will implement certain recommendations to improve it. However, most responders to a survey on the website, launched April 19, said they found it to be very useful. The website now includes links to various device-related databases and the CDRH management directory, and includes information on topics such as health hazard evaluations and health risk assessments. It also recently added a chart that explains to manufacturers and patients how adverse events are processed by the agency. (See "1FDA To Manufacturers: Describe Adverse Events More Fully"

Senate Drug Pricing Bill Lowers Manufacturer Discounts In Part D Catastrophic Phase

Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.

Topics

UsernamePublicRestriction

Register

MT036501

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel